The Medeleo polymedication review gathers all the necessary information for doctors to make educated decisions towards deprescribing drugs and improve a patient's well-being.
Learn why deprescription is important here.
Researchers and healthcare professionals work hard to produce deprescription guidelines. Unfortunately, they are hard to apply, scattered across the web and often overlooked.
Medeleo is a web-based tool that supports safe and informed decision-making when deprescribing medications that no longer benefit patients.
It contains:
It's a point of care polymedication review
So far, the Medeleo polymedication review is targeted towards the Swiss population. The report can be ordered by:
Yes! It is covered by LAMal as a consultation
The Medeleo polymedication review will be covered by the mandatory basic health insurance in Switzerland as a pharmacological consultation.
We are working hard to make it available in Switzerland by the end of 2025.
Register your interest by signing up to our newsletter and we'll keep you updated!
We are a team of computer scientists and pharmacologists who are passionate about improving the quality of life for patients.
We are proud to have received the following awards
"Quality of life of patients"
10th edition of the Debiopharm-La Solution.ch-Inartis Challenge
Follow us and we'll keep you up to date about our progress